Relmada Therapeutics (RLMD) null Earnings

13NovConfirmed
Feb 18
May 18
Sep 18
Nov 18
-0.46
-0.39
-0.33
-0.26

Details

Expected EPS
N/A
Actual EPS
-0.27
Surprise EPS
-0.27
Surprise Percent
+∞%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.27 per share for .

0 Comments

Share your thoughts